128 related articles for article (PubMed ID: 6525601)
1. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
Gams RA; Nelson O; Birch R
Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
DeSimone PA; Gams R; Birch R
Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
[No Abstract] [Full Text] [Related]
4. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
Williams SD; Birch R; Gams R; Irwin L
Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
[No Abstract] [Full Text] [Related]
5. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
[No Abstract] [Full Text] [Related]
6. Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
DeSimone PA; Gams R; Bartolucci A
Cancer Treat Rep; 1986 Jul; 70(7):929-30. PubMed ID: 3521850
[No Abstract] [Full Text] [Related]
7. Phase II clinical trial of diaziquone in bronchogenic carcinoma.
Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M
Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800
[No Abstract] [Full Text] [Related]
8. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
[No Abstract] [Full Text] [Related]
9. [Phase II study of mitoxantrone].
Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
[TBL] [Abstract][Full Text] [Related]
10. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Greco A; Prestridge K; Johnson R
Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833
[No Abstract] [Full Text] [Related]
11. Phase II trial of mitoxantrone in patients with primary liver cancer.
Falkson G; Coetzer BJ; Terblanche AP
Cancer Treat Rep; 1984 Oct; 68(10):1311-2. PubMed ID: 6525607
[No Abstract] [Full Text] [Related]
12. [The role of chemotherapy in metastatic pulmonary tumors in a disease-oriented phase II study of anticancer agent].
Fujita J; Saijo N
Gan No Rinsho; 1985 Aug; 31(10):1241-6. PubMed ID: 3903252
[TBL] [Abstract][Full Text] [Related]
13. Phase II clinical trials.
Carter SK; Selawry O
Natl Cancer Inst Monogr; 1977 Mar; (45):81-92. PubMed ID: 337157
[No Abstract] [Full Text] [Related]
14. Clinical evaluation of an innoxious antineoplastic agent: preliminary study of 106 patients treated with or without RSV after pulmonary resection for bronchogenic carcinoma.
Hansen JL
Cancer Chemother Rep 3; 1973 Mar; 4(2):261-4. PubMed ID: 4729327
[No Abstract] [Full Text] [Related]
15. Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck. A Southeastern Cancer Study Group trial.
Williams SD; Birch R; Velez-Garcia E; Gams R
Invest New Drugs; 1985; 3(3):311-3. PubMed ID: 4066226
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study.
Eisenhauer EA; Evans WK; Raghavan D; Desmeules MJ; Murray NR; Stuart-Harris R; Wilson KS
Cancer Treat Rep; 1986 Aug; 70(8):1029-30. PubMed ID: 3731150
[No Abstract] [Full Text] [Related]
17. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
Takita H; Brugarolas A; Mittelman A; Vincent R
Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
[No Abstract] [Full Text] [Related]
18. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
Levin M; Pandya KJ; Khandekar JD; Horton J; Glick JH; Bennett JM; Muggia FM; Falkson G
Cancer Treat Rep; 1984 Dec; 68(12):1511-2. PubMed ID: 6509455
[No Abstract] [Full Text] [Related]
19. Initial therapeutic trial of new drugs in lung cancer.
Selawry OS
Cancer Chemother Rep 3; 1973 Mar; 4(2):215-25. PubMed ID: 4729325
[No Abstract] [Full Text] [Related]
20. Phase II study of mitoxantrone in patients with non-small cell lung cancer.
Suga J; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Sano T; Tamura T; Hoshi A
Jpn J Clin Oncol; 1986 Jun; 16(2):147-51. PubMed ID: 3735704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]